TY - JOUR
T1 - Developments in treating the nonmotor symptoms of stroke
AU - Hillis, Argye E.
N1 - Funding Information:
This work was supported by the National Institutes of Health (NIDCD) through [R01 DC05375, R01 DC015466, and P50014664].
Publisher Copyright:
© 2020, © 2020 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2020/6/2
Y1 - 2020/6/2
N2 - Introduction: Stroke is among the most common causes of disability worldwide. Nonmotor symptoms of stroke are common and disabling. Many are treatable, and intervention improves the quality of life for stroke survivors. Areas covered: Here the author summarizes the evidence-based treatment of depression and other mood disorders, aphasia, hemispatial neglect, impairments of emotional communication and empathy, deficits in memory and other cognitive functions, sleep disorders, pain, fatigue, and seizures resulting from stroke. The author focuses on treatments supported by randomized controlled trials (RCTs), from the literature cited in Google Scholar, Embase, and Pubmed. Expert opinion: While behavioral rehabilitation is the most common intervention for many of the sequelae of stroke, relatively small RCTs support the use of noninvasive brain stimulation (transcranial direct current stimulation and transcranial direct current stimulation) and medications that facilitate neural plasticity and recovery. These noninvasive brain stimulation methods remain investigational for post-stroke symptoms. The strongest evidence for pharmacological intervention is in the domains of post-stroke mood disorders and epilepsy, but additional RCTs are needed to confirm the efficacy of selective serotonin reuptake inhibitors and other medications for improving recovery of cognition, language, and energy after stroke.
AB - Introduction: Stroke is among the most common causes of disability worldwide. Nonmotor symptoms of stroke are common and disabling. Many are treatable, and intervention improves the quality of life for stroke survivors. Areas covered: Here the author summarizes the evidence-based treatment of depression and other mood disorders, aphasia, hemispatial neglect, impairments of emotional communication and empathy, deficits in memory and other cognitive functions, sleep disorders, pain, fatigue, and seizures resulting from stroke. The author focuses on treatments supported by randomized controlled trials (RCTs), from the literature cited in Google Scholar, Embase, and Pubmed. Expert opinion: While behavioral rehabilitation is the most common intervention for many of the sequelae of stroke, relatively small RCTs support the use of noninvasive brain stimulation (transcranial direct current stimulation and transcranial direct current stimulation) and medications that facilitate neural plasticity and recovery. These noninvasive brain stimulation methods remain investigational for post-stroke symptoms. The strongest evidence for pharmacological intervention is in the domains of post-stroke mood disorders and epilepsy, but additional RCTs are needed to confirm the efficacy of selective serotonin reuptake inhibitors and other medications for improving recovery of cognition, language, and energy after stroke.
KW - Stroke
KW - aphasia
KW - cognitive impairment
KW - depression
KW - fatigue
KW - medication
KW - rehabilitation
KW - transcranial direct current stimulation
UR - http://www.scopus.com/inward/record.url?scp=85084859406&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85084859406&partnerID=8YFLogxK
U2 - 10.1080/14737175.2020.1763173
DO - 10.1080/14737175.2020.1763173
M3 - Review article
C2 - 32363957
AN - SCOPUS:85084859406
SN - 1473-7175
VL - 20
SP - 567
EP - 576
JO - Expert Review of Neurotherapeutics
JF - Expert Review of Neurotherapeutics
IS - 6
ER -